Literature DB >> 23429547

Genetic causes of developmental disorders.

Jacob A S Vorstman1, Roel A Ophoff.   

Abstract

PURPOSE OF REVIEW: Developmental disorders, including intellectual disability, autism and attention deficit hyperactivity disorder (ADHD), are neuropsychiatric disorders that manifest in early childhood as deviations from the normal development. At present, in the majority of cases a cause cannot be found. However, in the past 5 years major advances have been made in the identification of specific genetic causes of these disorders. Here, we review these findings and discuss possible implications for our current understanding of the cause of developmental disorders. RECENT
FINDINGS: In addition to the disorders with known genetic cause that are associated with intellectual disability, autism and ADHD, an increasing number of novel recurrent structural variants are identified in association with these developmental disorders. These variants, as well as the genetic variants identified through sequencing approaches indicate the involvement of a large number of genes.
SUMMARY: Similar to what is the case for intellectual disability, recent genetic studies indicate a large degree of genetic heterogeneity for autism and ADHD. Many of the disease risk variants display incomplete penetrance, indicating that additional genetic, and possibly nongenetic, factors are relevant. Despite the high number of causative or contributing genes, functional studies of these genes indicate a large degree of convergence into a smaller number of neurobiological pathways. Elucidating these shared biological mechanisms is a crucial step towards the rational development of novel therapeutic interventions.

Entities:  

Mesh:

Year:  2013        PMID: 23429547     DOI: 10.1097/WCO.0b013e32835f1a30

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  21 in total

Review 1.  The developmental stages of synaptic plasticity.

Authors:  Christian Lohmann; Helmut W Kessels
Journal:  J Physiol       Date:  2013-10-21       Impact factor: 5.182

Review 2.  Using genetic findings in autism for the development of new pharmaceutical compounds.

Authors:  Jacob A S Vorstman; Will Spooren; Antonio M Persico; David A Collier; Stefan Aigner; Ravi Jagasia; Jeffrey C Glennon; Jan K Buitelaar
Journal:  Psychopharmacology (Berl)       Date:  2013-11-30       Impact factor: 4.530

Review 3.  Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome.

Authors:  Ania M Fiksinski; Maude Schneider; Clodagh M Murphy; Marco Armando; Stefano Vicari; Jaume M Canyelles; Doron Gothelf; Stephan Eliez; Elemi J Breetvelt; Celso Arango; Jacob A S Vorstman
Journal:  Am J Med Genet A       Date:  2018-09-08       Impact factor: 2.802

4.  Population impact of preterm birth and low birth weight on developmental disabilities in US children.

Authors:  Laura A Schieve; Lin H Tian; Kristin Rankin; Michael D Kogan; Marshalyn Yeargin-Allsopp; Susanna Visser; Deborah Rosenberg
Journal:  Ann Epidemiol       Date:  2016-03-22       Impact factor: 3.797

Review 5.  Imaging genetics in neurodevelopmental psychopathology.

Authors:  Marieke Klein; Marjolein van Donkelaar; Ellen Verhoef; Barbara Franke
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-07       Impact factor: 3.568

6.  Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study.

Authors:  A M Fiksinski; E J Breetvelt; S N Duijff; A S Bassett; R S Kahn; J A S Vorstman
Journal:  Schizophr Res       Date:  2017-01-21       Impact factor: 4.939

7.  Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.

Authors:  Sarah E Soden; Carol J Saunders; Laurel K Willig; Emily G Farrow; Laurie D Smith; Josh E Petrikin; Jean-Baptiste LePichon; Neil A Miller; Isabelle Thiffault; Darrell L Dinwiddie; Greyson Twist; Aaron Noll; Bryce A Heese; Lee Zellmer; Andrea M Atherton; Ahmed T Abdelmoity; Nicole Safina; Sarah S Nyp; Britton Zuccarelli; Ingrid A Larson; Ann Modrcin; Suzanne Herd; Mitchell Creed; Zhaohui Ye; Xuan Yuan; Robert A Brodsky; Stephen F Kingsmore
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

8.  Bifenthrin causes transcriptomic alterations in mTOR and ryanodine receptor-dependent signaling and delayed hyperactivity in developing zebrafish (Danio rerio).

Authors:  Daniel F Frank; Galen W Miller; Danielle J Harvey; Susanne M Brander; Juergen Geist; Richard E Connon; Pamela J Lein
Journal:  Aquat Toxicol       Date:  2018-04-18       Impact factor: 4.964

Review 9.  Autism genetics: opportunities and challenges for clinical translation.

Authors:  Jacob A S Vorstman; Jeremy R Parr; Daniel Moreno-De-Luca; Richard J L Anney; John I Nurnberger; Joachim F Hallmayer
Journal:  Nat Rev Genet       Date:  2017-03-06       Impact factor: 53.242

Review 10.  Harnessing rare variants in neuropsychiatric and neurodevelopment disorders-a Keystone Symposia report.

Authors:  Jennifer Cable; Ryan H Purcell; Elise Robinson; Jacob A S Vorstman; Wendy K Chung; John N Constantino; Stephan J Sanders; Mustafa Sahin; Ricardo E Dolmetsch; Bina Maniar Shah; Audrey Thurm; Christa L Martin; Carrie E Bearden; Jennifer G Mulle
Journal:  Ann N Y Acad Sci       Date:  2021-08-02       Impact factor: 6.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.